Llwytho...

Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones

BACKGROUND AND OBJECTIVES: Higher urinary uric acid excretion is a suspected risk factor for calcium oxalate stone formation. Febuxostat, a xanthine oxidoreductase inhibitor, is effective in lowering serum urate concentration and urinary uric acid excretion in healthy volunteers and people with gout...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Goldfarb, David S., MacDonald, Patricia A., Gunawardhana, Lhanoo, Chefo, Solomon, McLean, Lachy
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Nephrology 2013
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3817901/
https://ncbi.nlm.nih.gov/pubmed/23929928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.01760213
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!